Manufacturing
EMA issues Q&A guideline on additive manufacturing
EMA has published a new Q&A guideline focused on GMP and quality aspects related to 3D printing in pharmaceutical manufacturing. The document applies to human and veterinary medicines as well as investigational products
IFPMA’s position on AI in pharmaceutical manufacturing
Artificial Intelligence (AI) and Machine Learning (ML) are playing an increasingly central role in pharmaceutical manufacturing and control. A position paper published by IFPMA in March 2026 outlines both the opportunities and the challenges associated with their adoption across the sector
R&D
More than €830 million awarded through ERC Advanced Grants 2025
The European Research Council has announced the results of the 2025 Advanced Grants competition, allocating a total of €838 million to support frontier research projects led by established scientists across Europe.The grants are designed to enable ambitious, high-risk, high-gain research that could lead to major scientific breakthroughs
Latest EFPIA’s data on the social and economic value of pharmaceutical...
Investment in innovative medicines should be regarded not merely as a healthcare expenditure but as a driver of substantial social and economic value. This is the key finding of EFPIA’s latest comprehensive study on the value of pharmaceutical innovation, published in June 2026


















